Ali Mokhtar Mahmoud

8PUBLICATIONS
26CO-AUTHORS
Biologically active moleculesCharacterisation of biological macromoleculesCellular interactions (incl. adhesion, matrix, cell wall)Cheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 19, 2024
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo.

Claudia Mugnaini, Antonella Brizzi, Marco Paolino

|Dec 11, 2022
N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation.

Eleonora Gianquinto, Federica Sodano, Barbara Rolando

|Aug 06, 2021
Sesquiterpene Lactones with the 12,8-Guaianolide Skeleton from Algerian Centaurea omphalotricha.

Sara Kebbi, Maria Letizia Ciavatta, Ali Mokhtar Mahmoud

|Jun 02, 2021
Modulation of Endocannabinoid Tone in Osteoblastic Differentiation of MC3T3-E1 Cells and in Mouse Bone Tissue over Time.

Magdalena Kostrzewa, Ali Mokhtar Mahmoud, Roberta Verde

|Sep 28, 2020
Correction to Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo.

Claudia Mugnaini, Magdalena Kostrzewa, Marta Bryk

|Jun 10, 2020
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo.

Claudia Mugnaini, Magdalena Kostrzewa, Marta Bryk

Pageof 2

Frequent Collaborators

7 joint publications

Alessia Ligresti

3 joint publications

Claudia Mugnaini

2 joint publications

Magdalena Kostrzewa

2 joint publications

Federico Corelli